Document is current
Any future updates will be listed below
-
Authors
Niespodziana, Katarzyna
Stenberg-Hammar, Katarina
Megremis, Spyridon
Cabauatan, Clarissa R.
Napora-Wijata, Kamila
Vacal, Phyllis C. http://orcid.org/0000-0003-3846-3812
Gallerano, Daniela
Lupinek, Christian
Ebner, Daniel
Schlederer, Thomas
Harwanegg, Christian
Söderhäll, Cilla
van Hage, Marianne
Hedlin, Gunilla
Papadopoulos, Nikolaos G.
Valenta, Rudolf
- License Information
-
More Information
Article History
Received: 3 January 2018
Accepted: 7 May 2018
First Online: 18 June 2018
Competing interests
: C.L. and M.v.H. report personal fees from Thermo Fisher Scientific, outside the submitted work. M.v.H. serves as a consultant for Biomay AG, Vienna, Austria and Hycor Biomedical LLC, CA, US. N.G.P. reports personal fees from Novartis, Faes Farma, Biomay AG, Vienna, Austria, HAL, Nutricia Research, Menarini, MEDA, Abbvie, MSD, Omega Pharma, Danone, grants from Menarini, outside the submitted work. R.V. reports grants from European Union, grants and personal fees from Biomay AG, Vienna, Austria, grants and personal fees from Viravaxx, Vienna, Austria, during the conduct of the study; grants from Austrian Science Fund (FWF), grants and personal fees from Biomay AG, Vienna, Austria, grants and personal fees from Viravaxx AG, Vienna, Austria, outside the submitted work. In addition, R.V. and K.N. are co-inventors in a patent application (PCT/AT2010/000416) regarding the rhinovirus diagnosis reported in this paper. The remaining authors declare no competing interests.
